Last update: June 15, 2019
Not risky for breastfeeding or infant.
Oral, intramuscular or intravenous administration in 3 to 4 daily doses.
Excreted in non-significant level into breast milk (Zhang 1997, Matsuda 1984, Stéen 1982, Smith 1975).
Except for few cases of enterocolitis due to disturbance of intestinal flora no other harm effects have been shown in breastfed infants. All cases spontaneously cured after discontinuation of medication.
One reported case (Mann 1980) of pseudomembrane colitis in an infant whose mother was on clindamicin and gentamicin.
Be aware of false negative results of bacterial cultures obtained from febrile infants whose mothers are on antibiotics, as well as the possibility of gastroenteritis due to altered intestinal flora (Ito 1993).
Expert authors consider the use of this medication safe or probably safe during breastfeeding (Hale 2019, Briggs 2017, Amir 2014 y 2011, Mitrano 2009, Spencer 2008, Schaefer 2007).
American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM